GHK is a tripeptide naturally present in human plasma, and complexed with copper ions it becomes GHK-Cu (copper peptide). It has 50+ years of accumulated data for collagen/elastin synthesis, anti-inflammation, antioxidation, and wound healing. Topical concentrations typically range 0.05-5%.

Is 2% a typical concentration?

Standard efficacious concentrations for GHK-Cu in topicals run 0.5-2%. 2% is at the upper efficacy range, with limited safety data above. Neurogan's 2% positions as one of the higher-concentration body care products on the market.

How does face vs body peptide application differ?

Facial skin has thinner epidermis and faster absorption, while body skin requires additional penetration enhancers (glycerin, AHA carriers). Body peptides typically use higher concentrations or co-formulated absorption boosters, and unit pricing per volume can run higher than facial counterparts.

Neurogan's 2% Copper Peptide Body Care Cuts Wrinkle Depth 32.8% in 12-Week Trial

The peptide market is expanding from face to body. Neurogan Health’s April 2026 launch of a 2% GHK-Cu body care reported 32.8% wrinkle depth reduction and 20-30% skin firmness improvement in a 12-week trial, signaling that peptide anti-aging mechanics, which historically lived on the face, can extend to the body.

Trial design and results

The 12-week trial highlighted two figures: 32.8% wrinkle depth reduction and 20-30% skin firmness improvement. While sample size and design specifics are limited externally, what matters is that the effect size matches established GHK-Cu topical literature, now reproduced in body application.

The most-cited GHK-Cu metrics: 31.6% wrinkle volume reduction vs Matrixyl 3000, 55.8% wrinkle volume reduction vs control, 32.8% wrinkle depth reduction. Neurogan’s 32.8% lines up exactly with the standard reading, framing the message that the same mechanism produces the same intensity in body skin.

GHK-Cu mechanism

GHK is a naturally occurring tripeptide in human plasma. Bound to copper ion, GHK-Cu has 50+ years of cumulative literature, with multi-layer mechanisms.

Collagen and elastin synthesis: direct action on dermal fibroblasts
Anti-inflammation: NF-κB pathway suppression, reduced inflammatory cytokines
Antioxidation: SOD activity stimulation
Wound healing: tissue regeneration via microRNA expression
Microcirculation: VEGF (angiogenesis factor) activation

While other peptides (Matrixyl, Signaline) work largely along single mechanisms, GHK-Cu touches five pathways simultaneously, characterized as “broad-spectrum rather than precision.”

What 2% means

Standard topical GHK-Cu efficacy ranges 0.5-2%. Below 0.05% is essentially marketing inclusion. 0.5-1% sits at standard efficacy, 1.5-2% at premium. 2% is near the ceiling, with limited safety data above. Neurogan’s 2% places it in the upper tier of comparable products.

Pricing varies widely by form and concentration: injectable single-use vials at $60-80, powders at $25-75, cosmetic formulations at $40-180. Body care has higher per-product cost given larger volumes, even at the same concentration.

Why face-to-body matters

The launch reads as more than a new product. Two reasons.

First, body anti-aging market formation. Body care’s traditional anchor was moisturizing + UV protection, with anti-aging claims rare. When peptide trial data reproduces in body, the mechanism-level anti-aging that lived on the face has the path to migrate to body.

Second, GLP-1 era demand shifts. Wegovy, Ozempic, and Mounjaro users experiencing rapid weight loss have generated a new aesthetic medicine category around skin laxity. Beyond procedural fixes in clinics, demand is forming around at-home, daily-use anti-aging that bridges the gap. Body peptides land squarely in that demand.

Peptide search trend backing

The supporting data is search trends. As of April 2026, “peptide therapy” was up 281% YoY on Google, 459% on TikTok, 412% on Instagram. Co-search terms grew sharply: NAD up 601%, GLP-1 up 177%, anti-aging up 162%. Peptides are no longer a single category but the intersection point of NAD, GLP-1, and anti-aging consumer interest.

What to verify

GHK-Cu topicals are generally a safe category. Side effect reports are rare; patch testing is recommended. Items to check before purchase:

Concentration label: “Contains GHK-Cu” alone may mean 0.01%. Verify efficacious concentration (0.5%+).
Stability: copper peptides are sensitive to light and oxygen, requiring opaque packaging and antioxidant formulation.
Vitamin C combination: simultaneous use reduces GHK-Cu activity (vitamin C reduces copper). Stagger times or alternate days.
Pricing: same efficacy concentration can show 5-10x unit price variance. Compare by concentration and volume.

What’s next

Neurogan’s launch signals body anti-aging market formation. The standard face anti-aging frame (retinol, vitamin C, peptides, hyaluronic acid) is starting to migrate to body, and topical peptides as adjuncts to aesthetic medicine procedures may settle as a distinct category. Korean K-beauty body peptide lines are expected to launch in earnest by H2 2026.

Source: Glossy / Neurogan Health